Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • The_Dark_Base
    Junior Member
    • Aug 2010
    • 6

    #1

    Ion Sphere ID summary, polyclonal %

    For our first runs we have "Filtered: Polyclonal" in the 25-35% range. Is this due to more beads put into the emulsions than necessary, non-accurate library titration or possibly >1 bead in a well? Is this percentage in the expected range?
    Last edited by The_Dark_Base; 12-20-2011, 04:40 PM.
  • ionman
    Junior Member
    • Nov 2011
    • 2

    #2
    Hi There,
    the polyclonal filter filters out beads that are estimated to have more than one template per ISP. Due to the nature of the protocol there always be some beads with more than one template on them. However, for a good quality run the "polyclonal" figure should be below 10%. Generally, high polyclonal figures isuggest ePCR titration issue.
    See also "ISP Identification Summary" on the Ion Community:

    Comment

    • IonTorrent
      Member
      • Jan 2010
      • 64

      #3
      I concur, ionman. If you've upgraded to software v1.5.1 (and you should! lots of great improvements in there), here is an updated description of the ISP summary table, including the changes made to improve estimation of polyclonality:

      Comment

      • SeqAA

        #4
        Most of the 1.5 reports seem to have higher polyclonal numbers than previous versions. I think they have changed the way it filters a couple times, so you can't compare to older reports.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 10:52 AM
        0 responses
        8 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-13-2026, 09:56 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-09-2026, 11:14 AM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Working...